Commonwealth Equity Services’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-98
Closed -$1K 3872
2022
Q3
$1K Sell
98
-7
-7% -$245 ﹤0.01% 3661
2022
Q2
$5K Hold
105
﹤0.01% 3650
2022
Q1
$14K Sell
105
-7
-6% -$1.02K ﹤0.01% 3676
2021
Q4
$19K Sell
112
-7
-6% -$2.61K ﹤0.01% 3609
2021
Q3
$59K Hold
119
﹤0.01% 3485
2021
Q2
$59K Buy
119
+2
+2% +$1.07K ﹤0.01% 3450
2021
Q1
$59K Hold
117
﹤0.01% 3322
2020
Q4
$55K Buy
117
+7
+6% +$2.3K ﹤0.01% 3123
2020
Q3
$31K Buy
110
+40
+57% +$9.91K ﹤0.01% 2987
2020
Q2
$13K Hold
70
﹤0.01% 2925
2020
Q1
$8K Buy
70
+29
+71% +$5.25K ﹤0.01% 2796
2019
Q4
$7K Sell
41
-11
-21% -$1.42K ﹤0.01% 2875
2019
Q3
$7K Hold
52
﹤0.01% 2828
2019
Q2
$6K Buy
52
+18
+53% +$2.85K ﹤0.01% 2767
2019
Q1
$5K Buy
+34
New +$5.82K ﹤0.01% 2739
2018
Q1
Sell
-122
Closed -$149K 2797
2017
Q4
$149K Buy
+122
New +$57.4K ﹤0.01% 2454

Other funds holding AMPE

Commonwealth Equity Services's AMPE Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 98 shares — an estimated $1K sold.

Commonwealth Equity Services first reported a position in AMPE in Q4 2017 and held it in 16 quarters. The position peaked at $149K in Q4 2017. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 98 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Commonwealth Equity Services first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 16 quarters.
  • Commonwealth Equity Services's Ampio Pharmaceuticals Inc. position peaked at $149K in Q4 2017.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.